Breast Biopsy in Ankara, Turkey

Breast biopsy is an invasive procedure performed to diagnose a mass or abnormal tissue detected in the breast. A sample is taken from the suspicious lesion and examined pathologically in a laboratory to determine whether it is benign or malignant.

Fine needle aspiration biopsy, core needle (tru-cut) biopsy, and excisional biopsy are the most commonly performed methods. The choice of method is determined according to the size, location, and imaging findings of the mass.

The biopsy procedure is generally performed under local anesthesia and guided by ultrasound or mammography. Mild pain, bruising, or swelling may occur after the procedure, but serious complications are uncommon.

The result of a breast biopsy is of critical importance for treatment planning. If cancer is diagnosed, the patient is directed to advanced treatments such as surgery, chemotherapy, or radiotherapy. Early diagnosis and the correct biopsy method increase the chance of success.

You can contact Prof. Dr. Ebru Soy, one of the doctors performing Breast Biopsy in Ankara, to get information about Breast Biopsy prices, the process, and the hospital where Breast Biopsy is performed.

What Is a Breast Biopsy?

Breast biopsy is a diagnostic procedure performed to determine the nature of an abnormal mass or tissue detected in the breast. During this procedure, a tissue sample is taken from the suspicious area and examined pathologically in the laboratory. It plays an important role in distinguishing benign and malignant lesions, especially breast cancer. Various biopsy methods include needle biopsy, tru-cut biopsy, and surgical biopsy.

Why Is a Breast Biopsy Performed and How Does It Differ from Traditional Methods?

When we look back at past years, the approach was quite different when an area that could not be felt by hand but appeared suspicious on imaging methods such as mammography or ultrasound was detected. In the past, such cases required removal of that area directly under operating room conditions with a surgical procedure. This was called diagnostic surgery. However, this approach brought a very challenging process for patients. In addition to physical burdens such as receiving anesthesia, having an incision scar on the body, deformities in breast tissue, and the recovery process, there was also the psychological burden of feeling “I had surgery for nothing” if the result turned out to be benign.

Today, there has been a significant paradigm shift in the medical world. Our basic philosophy is now to know exactly what we are dealing with before using a scalpel. At this point, “minimally invasive” methods, meaning those that cause the least damage to the body, come to the forefront. Percutaneous breast biopsy, that is, biopsy procedures performed through the skin with a needle, is the gold standard for tissue diagnosis today. This method offers countless advantages compared to the traditional open surgical biopsy.

First of all, these procedures are much less traumatic. Instead of a large incision requiring stitches on the skin, only a millimetric opening is made for the needle to enter. This means almost no scarring after the procedure and no deformation in the breast shape such as indentation or distortion. In addition to cosmetic results, complication rates such as infection or hematoma are incomparably lower than surgery.

However, the greatest strategic advantage of this method is that it strengthens the surgeon’s hand. When a definitive diagnosis is made with needle biopsy before surgery, your surgeon can plan the operation in a single session and in the most accurate way. If the result is cancer, how much tissue will be removed and whether the axillary lymph nodes will be intervened is determined from the beginning according to the tumor’s characteristics. Thus, the patient does not have to undergo separate surgeries for diagnosis and treatment. Treatment can be completed in a single session.

The decision for biopsy is not arbitrary. Radiologists report the images they obtain according to international standards, namely the BI-RADS classification. Situations in which biopsy is generally recommended include:

• Findings classified as BI-RADS 4
• Findings classified as BI-RADS 5
• Suspicious microcalcifications
• Areas of architectural distortion
• Newly developed asymmetric densities

Findings in these categories must be confirmed with a tissue sample because they carry suspicion of cancer.

What Are the Technical Differences Between Standard Core Needle Biopsy (CNB) and Vacuum-Assisted Biopsy (VAB)?

When biopsy is mentioned, patients usually think of a single type of needle; however, the situation is technically more complex. The success of the procedure and the accuracy of the diagnosis may vary depending on the needle system used. Basically, it is possible to talk about two main systems: Standard Core Needle Biopsy (CNB) and Vacuum-Assisted Biopsy (VAB).

Standard Core Needle Biopsy is a procedure performed with needles connected to an automatic gun system, which we have safely used for many years. Generally, 14-gauge needles are used. This method is quite effective, fast, and more cost-effective for masses that can be clearly visualized on ultrasound and have defined borders. The needle enters the mass, takes a piece, and is removed. This process needs to be repeated several times to obtain sufficient samples.

However, technology does not stand still, and Vacuum-Assisted Biopsy (VAB) systems come into play. These systems are thicker than standard needles (usually between 8 and 11 gauge). However, the main difference is not in thickness but in the working principle. In VAB systems, the needle is placed into the tissue once and is not removed again. The vacuum mechanism inside the needle pulls the surrounding suspicious tissue into the needle. The rotating blade system inside the needle cuts this tissue and collects it into a chamber.

The technical advantages provided by vacuum-assisted biopsy systems are:

• Greater tissue volume
• Multiple sampling with a single insertion
• Preservation of tissue integrity
• Control of bleeding with vacuum
• Wider sampling area

Studies show that vacuum systems provide on average 1.2 more and higher-quality tissue samples per procedure compared to standard needles. This means much richer material for the pathologist to examine under the microscope. Tissue quality is of vital importance, especially for performing sensitive tests such as hormone receptors that determine the biological character of the tumor.

In Which Cases Is Vacuum-Assisted Breast Biopsy (VAB) More Reliable Diagnostically?

Diagnostic accuracy is everything for a patient. The question “Is the result correct?” should not remain in anyone’s mind. Scientific data show that the overall diagnostic accuracy of the Vacuum-Assisted Biopsy (VAB) method is 94.8%, while standard core needle biopsy remains around 91.1%. Although this difference may seem small, in medicine it is considered a “significant difference” that can affect patient outcomes.

One of the most critical concepts here is “Malignant Underestimation.” Let us explain this further. Sometimes a needle biopsy is performed and the result comes back as “benign” or “risky but not cancer.” However, when the patient later undergoes surgery and the area is completely removed, it turns out that cancer was actually present. In other words, the needle biopsy has “underestimated” the seriousness of the disease. This is an undesirable surprise for both the patient and the physician and usually requires a second surgery.

The use of vacuum-assisted biopsy (VAB) significantly reduces this risk. Studies show that this margin of error can reach up to 30% in standard core needle biopsy, whereas it decreases to around 20% in vacuum-assisted biopsy. This approximately 10% difference makes VAB not just a preference but a necessity, especially in borderline cases. In addition, the possibility of what we call “false negative,” meaning saying “no cancer” when cancer is actually present, is much lower in vacuum-assisted biopsies.

The superiority of VAB is indisputable, especially in certain specific situations. These include:

• Microcalcifications
• Architectural distortions
• Heterogeneous lesions
• Very small masses
• Deeply located lesions

Especially in early-stage cancer suspicions presenting with calcifications, the area where calcifications are located must be extensively sampled. While a standard needle may miss the calcifications, the vacuum system sweeps that area and pulls the calcifications into its chamber, preventing missed diagnosis.

Which Imaging Methods Are Used During the Biopsy Procedure?

Breast biopsy is never a “guesswork” or blind procedure. The tip of the needle is followed within the tissue with millimetric precision. The imaging method to be used is determined according to which device best visualizes the suspicious finding.

The most commonly used method is Ultrasound-Guided Biopsy. This method is the most comfortable for both the patient and the physician. It is generally preferred for lesions seen as a mass or shadow on ultrasound. The patient lies on her back, and the radiologist holds the ultrasound probe with one hand to visualize the lesion on the screen while advancing the needle with the other hand. The entry of the needle into the mass and the sampling process are monitored in real time on the screen. It is fast, does not involve radiation, and is cost-effective.

Another method is Stereotactic Biopsy. This method is used especially for calcification (microcalcification) clusters that cannot be seen on ultrasound but are detected on mammography. Here, X-rays come into play. The patient lies face down on a special table or a special mammography device is used. The computer calculates the location of the lesion as coordinates in three-dimensional space. The needle is directed to these coordinates with robotic precision. During the procedure, images of the obtained samples are taken to confirm that the targeted calcifications have been correctly sampled.

The third and more specific method is MRI-Guided Biopsy. Sometimes the suspicious area is not seen on ultrasound or mammography and appears only on contrast-enhanced breast MRI. In this case, the biopsy must also be performed inside the MRI device. Because of the strong magnetic field, special metal-free (titanium or special alloy) needles are used. This is technically the most challenging and time-consuming method, but it is the only option for detecting some hidden cancers. Situations requiring MRI-guided biopsy generally include:

• Lesions visible only on MRI
• Suspicious contrast-enhancing areas
• Lesions showing washout with contrast

How Does Clip Placement and the Follow-Up Process Work After Biopsy?

After the biopsy procedure is completed, there is one more very important step to be taken: clip placement. Our patients sometimes worry, asking, “Will there be metal left inside me?” However, this procedure is indispensable. The clip is usually made of titanium or stainless steel, smaller than a grain of rice, and completely harmless to the body.

There are vital reasons for placing this clip in the biopsied area. Especially if we have removed the entire small lesion with vacuum-assisted biopsy, no visible trace may remain. If the pathology result turns out to be cancer, it becomes impossible for the surgeon to locate that area during surgery. The clip acts as a beacon for the surgeon, indicating, “The problematic area was here.” In addition, if the tumor completely disappears with chemotherapy, the tumor bed can still be located and cleaned thanks to the clip. Immediately after the biopsy, a control mammogram must be taken to confirm that the clip is in the correct position.

The biopsy process does not end with taking the tissue and sending it to the laboratory. After the result is obtained, a critical meeting called “Radiologic-Pathologic Concordance” is held. The following question is asked: “Does the result seen under the microscope explain the suspicious image we saw on the scan?”

If there is a very alarming, irregularly bordered mass suspicious for cancer on radiology, but the pathology result is completely benign, there is a “discordance.” This may be interpreted as, “The biopsy probably missed the actual malignant area and sampled adjacent healthy tissue.” In this case, the result is not trusted, and either the biopsy is repeated or the area is surgically removed. However, if the image and the result confirm each other (concordance), follow-up or treatment planning can proceed with confidence. In benign results, follow-up intervals are generally as follows:

• Control every 6 months in the first year
• Annual control in the second year
• If stable, routine screening

What Are the Risky Findings Known as B3 Lesions?

Biopsy results are not always black or white; that is, they do not always come back as either “cancer” or “completely clean.” Sometimes we encounter what we call “gray zone” results. This group, referred to in medical literature as “B3 Lesions” or “Lesions of Uncertain Malignant Potential,” is the most challenging to manage. They are not cancer, but they may carry a risk of turning into cancer or may hide an un-sampled cancer focus nearby.

One of the most common diagnoses in this group is Atypical Ductal Hyperplasia (ADH). This indicates that the cells in the milk ducts have begun to change shape but do not yet meet the full criteria for cancer. An ADH result on needle biopsy is an alarm bell for surgeons. Large-scale analyses show that approximately 30% (and up to 50% in some studies) of patients with ADH on needle biopsy actually have an accompanying cancer (DCIS or invasive cancer) when the area is surgically removed. Therefore, the standard approach in patients diagnosed with ADH is surgical excision of that area. Although close follow-up may be an option in very selected, low-risk patients whose entire lesion was removed by vacuum, the generally accepted approach is surgery.

Another important group is Lobular Neoplasia. These are also divided according to risk status. Classic Lobular Carcinoma In Situ (LCIS) or Atypical Lobular Hyperplasia (ALH) are usually found incidentally and, if compatible with imaging, have a low risk of progression to cancer (around 4%). In these patients, close follow-up is generally preferred instead of surgery. However, “Non-Classic” types (Pleomorphic or Florid LCIS) are much more dangerous. Their risk of association with cancer or progression to cancer ranges between 25% and 60%. Therefore, these diagnoses require surgical excision. During surgery, they must be removed with clear margins (usually a 2 mm clean margin) just like cancer surgery.

In summary, factors leading to surgical decision in the management of B3 lesions include:

• Radiologic and pathologic discordance
• Lesion size greater than 15 mm
• Patient age over 50
• Insufficient sampling in biopsy
• Presence of high-risk subtypes (Pleomorphic, etc.)

Why Is the Use of Magnetic Seed (Magseed) Important Instead of Wire in Breast-Conserving Surgery?

When a surgical decision is made as a result of biopsy and breast-conserving surgery (meaning only the diseased area is removed, not the entire breast) is planned, it is often not possible for the surgeon to locate that tissue by hand. This is because today we detect cancers very early, before they can be felt. In this case, preoperative localization is required.

For years, the “Wire Localization” method has been used for this purpose. On the morning of surgery, the patient goes to radiology, a hooked wire is placed in the breast, and the other end of the wire protrudes from the breast. However, this method presents serious challenges for both the patient and hospital workflow. The patient experiences significant stress while waiting to go to the operating room with a wire protruding from her breast, cannot move comfortably, and fears displacement of the wire. In addition, synchronizing the surgery time with the radiology appointment is a major organizational burden.

Most importantly, the entry point of the wire restricts the surgeon. The radiologist inserts the wire from the easiest location, but this may not be the cosmetically preferred incision site for the surgeon. In surgeries guided by wire, sometimes more tissue than necessary must be removed because the surgeon has to follow the path of the wire.

At this point, technology comes to the rescue with Magnetic Seed Localization (Magseed). In this method, a magnetic seed the size of a grain of rice can be placed into the tumor days or even weeks before surgery. It has no part protruding outward like a wire; it is completely under the skin.

The advantages provided by magnetic seed use include:

• Timing Flexibility: No stress on the day of surgery; the seed can be placed days in advance.
• Patient Comfort: Since there is no wire outside, the patient can continue daily life; pain and movement restriction are much less.
• Surgical Precision: The surgeon locates the seed with a special detector (probe). This system works like a metal detector and shows the exact center of the tumor with millimetric precision.
• Better Cosmetic Results: The surgeon can make the incision from the area that will least disrupt breast aesthetics, without being dependent on the wire entry site.
• Tissue Preservation: One of the most striking data points. Studies show that in surgeries using magnetic seeds, the volume of removed tissue is approximately 30% less compared to wire-guided surgeries. This means the tumor is targeted more precisely and unnecessary loss of healthy tissue is prevented.

Frequently Asked Questions

How long does the risk of bleeding last after a breast biopsy?

Mild bleeding or bruising after a breast biopsy may last a few days. Heavy bleeding is rare and usually occurs within the first 24 hours after the procedure. In case of prolonged bleeding, a doctor should be consulted.

Is breast biopsy safe during pregnancy?

Breast biopsy during pregnancy is usually performed with ultrasound-guided needle biopsy, and this method is safe because it does not require anesthesia. However, each patient should be evaluated individually.

How long does it take to receive breast biopsy results?

Results of needle biopsies are generally available within 3–5 business days. In open surgical biopsies, this period may extend up to 7 days. The exact duration depends on the technique used and laboratory workload.

Is hardness after breast biopsy normal?

Yes, hardness in the breast after biopsy may occur due to edema or internal bleeding and usually disappears within a few weeks. If the hardness increases or pain worsens, medical evaluation is recommended.

Does having a breast biopsy cause cancer to spread?

No, breast biopsy does not cause cancer to spread. Modern biopsy techniques obtain tissue in a sterile and controlled manner and do not negatively affect the course of the disease.

When can sports activities be resumed after a breast biopsy?

Heavy activities should be avoided for at least 48 hours after biopsy. Most patients can return to their normal exercise routine within a week.

How long does the breast biopsy procedure take and is it painful?

The procedure usually takes 15–30 minutes. Thanks to local anesthesia, pain is not felt; only brief pressure or a slight stinging sensation may occur.

Which methods are used in breast biopsy and how are they selected?

Fine needle aspiration, core needle (tru-cut) biopsy, and open surgical biopsy methods are used. The method is selected according to the size, location, and imaging findings of the mass.

Is there a risk of infection after breast biopsy?

The risk of infection is quite low but not completely zero. If redness, swelling, discharge, pain, or fever develops, a doctor should be consulted. Following hygiene rules reduces the risk.

How can psychological effects after breast biopsy be managed?

The biopsy process may cause anxiety due to uncertainty. Patient support groups, psychological counseling, and support from close relatives help reduce emotional burden during this period.

How Long Does a Breast Biopsy Take?

A breast biopsy generally takes between 15 and 60 minutes. The duration depends on the biopsy method used (such as needle biopsy, vacuum-assisted biopsy, or surgical biopsy) and the ease of accessing the mass.

Which Doctor or Department Should Be Consulted for a Breast Biopsy?

For a breast biopsy, the general surgery department should be consulted. Breast surgeons or general surgeons specialized in this field make the biopsy decision after necessary examination and imaging and perform the procedure. If imaging guidance is required, radiology specialists may also be involved in the process.

How is a breast biopsy performed?

Breast biopsy is the procedure of taking a sample from tissue found suspicious in the breast through imaging methods (ultrasound, mammography, or MRI) using a fine needle or core needle (tru-cut). The procedure is performed under sterile conditions, usually with imaging guidance, and completed in a short time. The obtained tissue is examined in the pathology laboratory for definitive diagnosis.

Is breast biopsy harmful?

Breast biopsy is a medically safe procedure and does not cause cancer to spread. Rarely, mild bleeding, bruising, or infection may occur. When performed with proper technique by an experienced physician, the risk of complications is very low.

Does breast biopsy hurt?

Since local anesthesia is applied before the procedure, pain is generally not felt. Only brief pressure or mild discomfort may occur at the moment of needle insertion. Tenderness after the procedure is usually mild and temporary.

What should be done after a breast biopsy?

After biopsy, the treated area should be kept clean and dry. It is recommended to avoid heavy exercise and strenuous activities for the first 24 hours. Mild pain or bruising is considered normal. However, if increasing swelling, redness, severe pain, or fever develops, a doctor should be consulted.

Is the patient put to sleep for a breast biopsy?

Most breast biopsies are performed under local anesthesia and do not require general anesthesia. The patient remains awake during the procedure but does not feel pain. General anesthesia may be preferred only in special cases requiring surgical biopsy.